行情

NEO

NEO

Neogenomics
NASDAQ

实时行情|Nasdaq Last Sale

24.07
+0.59
+2.51%
盘后: 24.07 0 0.00% 16:41 11/15 EST
开盘
23.45
昨收
23.48
最高
24.12
最低
23.44
成交量
48.72万
成交额
--
52周最高
26.89
52周最低
11.05
市值
25.07亿
市盈率(TTM)
1375.43
分时
5日
1月
3月
1年
5年

分析师评级

8位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

NEO 新闻

  • 汽油涨价引发大规模抗议 伊朗两天约千人被捕
  • 新浪美股.3小时前
  • 全球最大的IPO来了 沙特阿美IPO指导价敲定
  • 新浪财经综合.3小时前
  • 沙特阿美拟募资超240亿美元,整体估值达1.6万亿美元
  • 澎湃新闻.6小时前
  • 7000亿美元!金融业忽视女性每年付出的代价
  • 快科技.6小时前

更多

所属板块

医疗设施与服务
+3.51%
医疗保健提供商与服务
+4.46%

热门股票

名称
价格
涨跌幅

NEO 简况

NeoGenomics, Inc. is an operator of a network of cancer-focused genetic testing laboratories. The Company operates in Laboratory Testing Segment. This segment delivers testing services to hospitals, pathologists, oncologists, other clinicians and researchers. It has laboratory locations in Ft. Myers and Tampa, Florida; Aliso Viejo, Fresno, Irvine, and West Sacramento, California; Houston, Texas and Nashville, and Tennessee. It offers testing services, which include Cytogenetics, Fluorescence In-Situ Hybridization (FISH), Flow cytometry, Immunohistochemistry (IHC), Molecular testing and Pathology consultation. Its Pharma Services and Clinical Trials group provides testing services in support of its pharmaceutical clients' oncology programs from discovery to commercialization. It helps its customers develop a biomarker hypothesis by recommending an optimal platform for molecular screening and backing its discovery tools with the informatics to capture meaningful data.
展开

Webull提供NeoGenomics, Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。